I will keep fighting to hold Big Tobacco accountable and protect the next generation from nicotine addiction.
Keep fighting to hold Big Tobacco accountable and protect the next generation from nicotine addiction.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
Krishnamoorthi criticized FDA authorization of JUUL2 tobacco- and menthol-flavored products, said FDA should be cracking down on products that hook kids on nicotine, and stated he would keep fighting to hold Big Tobacco accountable and protect the next generation from nicotine addiction. The release also cites his role as co-chair of the Congressional Caucus to End Youth Vaping, prior investigations, FDA enforcement letters, and recent PROTECT Act introduction.
legacy_unverified · Source version not recorded · locator unknown
FDA authorized marketing of three JUUL2 e-cigarette products: a tobacco-flavored pod, a menthol-flavored pod, and the JUUL2 device. FDA said adult-switching benefits outweighed risks, including youth appeal, and reported 48 authorized e-cigarette products to date.
Assessments
Krishnamoorthi has taken same-term federal action consistent with the promise, including publicly opposing FDA authorization of JUUL2 products, co-chairing the Congressional Caucus to End Youth Vaping, pursuing investigations and enforcement pressure, and introducing or supporting related legislation such as the PROTECT Act. But the promised outcome is broad: holding Big Tobacco accountable and protecting the next generation from nicotine addiction. The available evidence shows continued advocacy and a recent FDA setback, not a completed federal policy result or accountability outcome. Because he is actively attempting to deliver the promise but the outcome remains unfinished, the best classification is unresolved with an effort badge.